IVERIC bio, Inc.

Ticker ISEE

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

11-50 Employees
Based in New York City, New York

IVERIC bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The Company is currently developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases. Vision is Our Mission.

Visit website

REPORT RATINGS

4.7 / 5.0 (173)

IVERIC bio, Inc. reports have an aggregate usefulness score of 4.7 based on 173 reviews.

IVERIC bio, Inc.